Age (years)*¥
|
56.14 (65.09-43.64)
|
55.69 (64.44-46.71)
|
48.24 (56.08-37.25)
|
<0.001
|
Males (%)
|
212 (28.4)
|
271 (57.8)
|
133 (39.5)
|
<0.001
|
Hypertension (%)
|
307 (41.1)
|
219 (46.7)
|
103 (30.6)
|
<0.001
|
Diabetes (%)
|
79 (10.6)
|
65 (13.9)
|
34 (10.1)
|
0.145
|
Dyslipidemia (%)
|
214 (28.6)
|
177 (37.7)
|
82 (24.3)
|
<0.001
|
Obesity (%)
|
161 (21.6)
|
114 (24.3)
|
62 (18.4)
|
0.124
|
Antihypertensive drugs (%)
|
223 (29.9)
|
162 (34.5)
|
66 (19.6)
|
<0.001
|
Lipid-lowering drugs (%)
|
126 (16.9)
|
122 (26.0)
|
48 (14.2)
|
<0.001
|
Antidiabetic drugs (%)
|
52 (7.0)
|
46 (9.8)
|
25 (7.4)
|
0.187
|
Office SBP (mmHg)*¥
|
123.75 (134.63-113.50)
|
125.50 (138.00-114.50)
|
121.25 (131.38-109.13)
|
<0.001
|
Office DBP (mmHg)
|
76.50 (83.50-70.50)
|
77.00 (83.38-70.00)
|
75.50 (82.50-70.00)
|
0.377
|
Office heart rate (bpm)*¥#
|
71.50 (78.50-64.50)
|
69.50 (76.50-61.13)
|
75.00 (82.63-67.00)
|
<0.001
|
Central SBP (mmHg)*¥
|
124 (135–114)
|
125 (137–115)
|
121 (132–110)
|
0.002
|
Central DBP (mmHg)
|
76 (83–70)
|
77 (84–70)
|
75 (82–68)
|
0.188
|
BMI (kg/m2)*¥
|
26.67 (29.56-24.05)
|
27.07 (29.96-24.90)
|
25.64 (28.52-22.90)
|
<0.001
|
Waist circumference (cm) ¥#
|
92 (100–84)
|
95 (104–88)
|
91.00 (99–82)
|
<0.001
|
Total cholesterol (mg/dL)
|
215.41 ± 38.77
|
213.36 ± 39.10
|
210.74 ± 39.28
|
0.192
|
Triglycerides (mg/dL)*
|
95 (133–69)
|
96 (136–73)
|
104 (147–75)
|
0.026
|
LDL-cholesterol (mg/dL)
|
133.85 ± 36.78
|
133.18 ± 34.89
|
132.36 ± 36.75
|
0.827
|
HDL-cholesterol (mg/dL)*#
|
59.00 (70.00-49.00)
|
56.00 (67.00-47.00)
|
54.00 (64.75-45.00)
|
<0.001
|
Mean IMT (mm) (n = 265) ¥
|
0.68 ± 0.10
|
0.70 ± 0.11
|
0.65 ± 0.11
|
0.045
|
Maximum IMT (mm) (n = 265) ¥
|
0.83 ± 0.12
|
0.86 ± 0.13
|
0.81 ± 0.13
|
0.042
|
PWV (m/sec) (n = 265)
|
7.10 (8.60-6.38)
|
7.30 (8.95-6.35)
|
6.65 (7.95-5.57)
|
0.032
|
PAIx75 (%) #¥
|
89 (101–78)
|
86 (97–75)
|
90 (103–77)
|
0.003
|
ABI #¥
|
1.17 ± 0.13
|
1.19 ± 0.14
|
1.16 ± 0.14
|
0.005
|